日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Layilin Anchors Regulatory T Cells in Skin

莱伊林锚定皮肤中的调节性T细胞

Pooja Mehta ,Victoire Gouirand ,Devi P Boda ,Jingxian Zhang ,Sofia V Gearty ,Bahar Zirak ,Margaret M Lowe ,Sean Clancy ,Ian Boothby ,Kelly M Mahuron ,Adam Fries ,Matthew F Krummel ,Parminder Mankoo ,Hsin-Wen Chang ,Jared Liu ,Joshua M Moreau ,Tiffany C Scharschmidt ,Adil Daud ,Esther Kim ,Isaac M Neuhaus ,Hobart W Harris ,Wilson Liao ,Michael D Rosenblum

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

耗竭的 T 细胞特征可预测 ER 阳性乳腺癌的免疫治疗反应

Manuela Terranova-Barberio, Nela Pawlowska, Mallika Dhawan, Mark Moasser, Amy J Chien, Michelle E Melisko, Hope Rugo, Roshun Rahimi, Travis Deal, Adil Daud, Michael D Rosenblum, Scott Thomas, Pamela N Munster

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

干扰素-γ介导的肿瘤特异性T细胞克隆清除赋予肿瘤对联合免疫检查点阻断疗法的耐药性

Chien-Chun Steven Pai ,John T Huang ,Xiaoqing Lu ,Donald M Simons ,Chanhyuk Park ,Anthony Chang ,Whitney Tamaki ,Eric Liu ,Kole T Roybal ,Jane Seagal ,Mingyi Chen ,Katsunobu Hagihara ,Xiao X Wei ,Michel DuPage ,Serena S Kwek ,David Y Oh ,Adil Daud ,Katy K Tsai ,Clint Wu ,Li Zhang ,Marcella Fasso ,Ravi Sachidanandam ,Anitha Jayaprakash ,Ingrid Lin ,Amy-Jo Casbon ,Gillian A Kinsbury ,Lawrence Fong

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

lincRNA MIRAT 与 IQGAP1 结合并调节 NRAS 突变黑色素瘤中的 MAPK 通路

Martina Sanlorenzo, Igor Vujic, Rosaura Esteve-Puig, Kevin Lai, Marin Vujic, Kevin Lin, Christian Posch, Michelle Dimon, Adrian Moy, Mitchell Zekhtser, Katia Johnston, Deborah Gho, Wilson Ho, Abhinay Gajjala, Juan Oses Prieto, Alma Burlingame, Adil Daud, Klemens Rappersberger, Susana Ortiz-Urda

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

PD-1 阻断剂派姆单抗治疗晚期默克尔细胞癌

Paul T Nghiem, Shailender Bhatia, Evan J Lipson, Ragini R Kudchadkar, Natalie J Miller, Lakshmanan Annamalai, Sneha Berry, Elliot K Chartash, Adil Daud, Steven P Fling, Philip A Friedlander, Harriet M Kluger, Holbrook E Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M Pardol

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer

BRAF 和 MEK 抑制剂联合达拉非尼和曲美替尼治疗 BRAF V600 突变型结直肠癌

Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, Eunice L Kwak, David P Ryan, Johanna C Bendell, Omid Hamid, Wells A Messersmith, Adil Daud, Razelle Kurzrock, Mariaelena Pierobon, Peng Sun, Elizabeth Cunningham, Shonda Little, Keith Orford, Monica Motwani, Yuchen Bai, Kiran Patel, Alan P Venook, 

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma

17-烯丙基氨基-17-去甲氧基格尔德霉素治疗转移性黑色素瘤的 II 期临床试验

David B Solit, Iman Osman, David Polsky, Katherine S Panageas, Adil Daud, James S Goydos, Jerrold Teitcher, Jedd D Wolchok, F Joseph Germino, Susan E Krown, Daniel Coit, Neal Rosen, Paul B Chapman